• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Analysis of the prevalence, spread, and mutation patterns of SARS-CoV-2 variants: data from COVID-19 testing expansion strategy study in s

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Aug 29;15(1):31866.
doi: 10.1038/s41598-025-17691-x. Analysis of the prevalence, spread, and mutation patterns of SARS-CoV-2 variants: data from COVID-19 testing expansion strategy study in salvador, Northeast Brazil

Anna Carolina Saúde Dantas[SUP] #[/SUP][SUP] 1 [/SUP], Hellen Braga Martins Oliveira[SUP] #[/SUP][SUP] 1 [/SUP], Taiana Tainá Silva Pereira[SUP] #[/SUP][SUP] 2 [/SUP], Amanda Ferreira Lima[SUP] 1 [/SUP], Leonardo Silva Santos[SUP] 1 [/SUP], Janaina Marinho Fernandes Matos[SUP] 1 [/SUP], Thaís Aranha[SUP] 3 4 [/SUP], Laio Magno[SUP] 3 4 [/SUP], Fabiane Soares[SUP] 4 [/SUP], Inês Dourado[SUP] 4 [/SUP], Thiago S Torres[SUP] 5 [/SUP], Valdiléa Gonçalves Veloso[SUP] 5 [/SUP], Orlando da Costa Ferreira Junior[SUP] 6 [/SUP], Laise de Moraes[SUP] 7 [/SUP], Luciane Amorim Santos[SUP] 7 [/SUP], Danielle Souto de Medeiros[SUP] 1 [/SUP], Fernanda Khouri Barreto[SUP] 1 [/SUP], Leandro Martins de Freitas[SUP] 1 [/SUP], Ana Marcia de Sá Guimarães[SUP] 2 [/SUP], Guilherme Barreto Campos[SUP] 1 [/SUP], Lucas Miranda Marques[SUP] 8 [/SUP]



Affiliations
Abstract

This study investigated the prevalence and genomic epidemiology of SARS-CoV-2 variants as part of the TQT-COVID-19 Project, which aimed to expand COVID-19 testing, quarantine, and telemonitoring strategies. A total of 177 samples were analyzed between July 2022 and April 2023 from patients of 17 Primary Health Care (PHC) units in Salvador, Bahia, Brazil. Sequencing was done using Oxford Nanopore MinION technology and bioinformatics analysis for variant typing and phylodynamic spread assessment. Most participants were women (68.5%), under 39 years old (48.9%), used public transportation (66.4%), had no comorbidities (66.1%), presented mild COVID-19 symptoms (40.8%), and had received a second booster dose of a COVID-19 vaccine (88.2%). Nevertheless, 11.8% had never received a COVID-19 vaccine. The most prevalent Omicron subvariants were BA.5 (32.6%), BA.4 (21.7%), B (18.8%), and BQ.1 (26.3%), with other variants like XBB also identified. Vaccinated and unvaccinated individuals had different spike gene mutations. While multiple variant introductions occurred over time, SARS-CoV-2 geographic spread was mainly localized, with occasional rapid spread associated with inter-city travel or containment failures. These findings underscore the need to track viral spread and mutations to develop targeted strategies for breaking transmission chains.

Keywords: Brazil; Genomic spread; Mutation analysis; SARS-CoV-2 variants; Superspreader events.

 
Back
Top Bottom